Tata Chemicals Share Price
Sector: Chemical Manufacturing
You have to be logged in to add this to Watchlist.
Login or Register
1056.55 -50.70 (-4.58%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1054.45
Today’s High
1111
52 Week Low
933
52 Week High
1349.7
1061.55 -45.70 (-4.13%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1060.05
Today’s High
1115.05
52 Week Low
933
52 Week High
1349
Key Metrics
- Market Cap (In Cr) 28207.89
- Beta 1.35
- Div. Yield (%) 1.35
- P/B 1.27
- TTM P/E -
- Sector P/E 23.11
- D/E 0.29
- Open Price 1111
- Prev Close 1107.25
Tata Chemicals Analysis
Price Analysis
-
1 Week3.11%
-
3 Months5.68%
-
6 Month-0.5%
-
YTD0.29%
-
1 Year14.91%
Risk Meter
- 33% Low risk
- 33% Moderate risk
- 33% Balanced Risk
- 33% High risk
- 33% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 0
- 0
- 0
- 0
- Buy
- 0
- 0
- 0
- 0
- Hold
- 1
- 1
- 1
- 1
- Sell
- 5
- 5
- 5
- 5
- Strong Sell
- 1
- 1
- 1
- 1
- Total
- 7
- 7
- 7
- 7
Tata Chemicals News
Stock market today: Nifty, Sensex fall on profit booking; mid, smallcaps bleed
4 min read . 21 Oct 2024Stocks to Watch: RIL, Bajaj Auto, L&T Tech, Oberoi Realty, RVNL, Crisil and more
2 min read . 17 Oct 2024Q2 Results Today: Infosys, Wipro, Axis Bank, among 36 companies to post earnings
2 min read . 17 Oct 2024Tata Chemicals Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 15421
- Selling/ General/ Admin Expenses Total
- 4128
- Depreciation/ Amortization
- 980
- Other Operating Expenses Total
- 3072
- Total Operating Expense
- 14415
- Operating Income
- 1006
- Net Income Before Taxes
- 830
- Net Income
- 268
- Diluted Normalized EPS
- 29.35
- Period
- 2024
- Total Assets
- 36756
- Total Liabilities
- 14515
- Total Equity
- 22241
- Tangible Book Valueper Share Common Eq
- 456.55
- Period
- 2024
- Cashfrom Operating Activities
- 3016
- Cashfrom Investing Activities
- -610
- Cashfrom Financing Activities
- -2494
- Net Changein Cash
- -83
- Period
- 2023
- Total Revenue
- 16789
- Selling/ General/ Admin Expenses Total
- 4764
- Depreciation/ Amortization
- 890
- Other Operating Expenses Total
- 661
- Total Operating Expense
- 13763
- Operating Income
- 3026
- Net Income Before Taxes
- 2740
- Net Income
- 2317
- Diluted Normalized EPS
- 93.38
- Period
- 2023
- Total Assets
- 35084
- Total Liabilities
- 15363
- Total Equity
- 19721
- Tangible Book Valueper Share Common Eq
- 360.78
- Period
- 2023
- Cashfrom Operating Activities
- 2971
- Cashfrom Investing Activities
- -1186
- Cashfrom Financing Activities
- -2076
- Net Changein Cash
- -254
- Period
- 2022
- Total Revenue
- 12622.12
- Selling/ General/ Admin Expenses Total
- 4024.72
- Depreciation/ Amortization
- 804.92
- Other Operating Expenses Total
- 482.52
- Total Operating Expense
- 11067.24
- Operating Income
- 1554.88
- Net Income Before Taxes
- 1666.63
- Net Income
- 1257.62
- Diluted Normalized EPS
- 49.41
- Period
- 2022
- Total Assets
- 33843.27
- Total Liabilities
- 15590.38
- Total Equity
- 18252.89
- Tangible Book Valueper Share Common Eq
- 329.14
- Period
- 2022
- Cashfrom Operating Activities
- 1644.33
- Cashfrom Investing Activities
- -836.14
- Cashfrom Financing Activities
- -755.25
- Net Changein Cash
- 72.19
- Period
- 2021
- Total Revenue
- 10199.8
- Selling/ General/ Admin Expenses Total
- 3496.03
- Depreciation/ Amortization
- 758.71
- Other Operating Expenses Total
- 509.78
- Total Operating Expense
- 9376.36
- Operating Income
- 823.44
- Net Income Before Taxes
- 633.99
- Net Income
- 256.37
- Diluted Normalized EPS
- 9.9
- Period
- 2021
- Total Assets
- 28337.2
- Total Liabilities
- 14047.23
- Total Equity
- 14289.97
- Tangible Book Valueper Share Common Eq
- 183.29
- Period
- 2021
- Cashfrom Operating Activities
- 2037.3
- Cashfrom Investing Activities
- -1130.31
- Cashfrom Financing Activities
- -1455.65
- Net Changein Cash
- -564.92
- Period
- 2020
- Total Revenue
- 10356.75
- Selling/ General/ Admin Expenses Total
- 3599.2
- Depreciation/ Amortization
- 665.81
- Other Operating Expenses Total
- 557.54
- Total Operating Expense
- 9035.73
- Operating Income
- 1321.02
- Net Income Before Taxes
- 1248.06
- Net Income
- 7006.33
- Diluted Normalized EPS
- 31.17
- Period
- 2020
- Total Assets
- 27688.75
- Total Liabilities
- 14791.09
- Total Equity
- 12897.66
- Tangible Book Valueper Share Common Eq
- 113.76
- Period
- 2020
- Cashfrom Operating Activities
- 1780.09
- Cashfrom Investing Activities
- -2368.23
- Cashfrom Financing Activities
- -129.26
- Net Changein Cash
- -634.12
- Period
- 2019
- Total Revenue
- 10336.72
- Selling/ General/ Admin Expenses Total
- 3627.51
- Depreciation/ Amortization
- 567.77
- Other Operating Expenses Total
- 583.43
- Total Operating Expense
- 9015.02
- Operating Income
- 1321.7
- Net Income Before Taxes
- 1437.26
- Net Income
- 1155.91
- Diluted Normalized EPS
- 34.92
- Period
- 2019
- Total Assets
- 26904.92
- Total Liabilities
- 14563.65
- Total Equity
- 12341.27
- Tangible Book Valueper Share Common Eq
- 120.62
- Period
- 2019
- Cashfrom Operating Activities
- 1582.33
- Cashfrom Investing Activities
- -1958.19
- Cashfrom Financing Activities
- -1711.83
- Net Changein Cash
- -2057.55
- Period
- 2024-09-30
- Total Revenue
- 3999
- Selling/ General/ Admin Expenses Total
- 1190
- Depreciation/ Amortization
- 277
- Other Operating Expenses Total
- 743
- Total Operating Expense
- 3658
- Operating Income
- 341
- Net Income Before Taxes
- 348
- Net Income
- 194
- Diluted Normalized EPS
- 7.61
- Period
- 2024-09-30
- Total Assets
- 37621
- Total Liabilities
- 15426
- Total Equity
- 22195
- Tangible Book Valueper Share Common Eq
- 453.49
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 673
- Cashfrom Investing Activities
- -564
- Cashfrom Financing Activities
- -91
- Net Changein Cash
- 25
- Period
- 2024-06-30
- Total Revenue
- 3789
- Selling/ General/ Admin Expenses Total
- 1144
- Depreciation/ Amortization
- 273
- Other Operating Expenses Total
- 726
- Total Operating Expense
- 3488
- Operating Income
- 301
- Net Income Before Taxes
- 269
- Net Income
- 150
- Diluted Normalized EPS
- 5.3
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 3475
- Selling/ General/ Admin Expenses Total
- 1139
- Depreciation/ Amortization
- 271
- Other Operating Expenses Total
- 783
- Total Operating Expense
- 4266
- Operating Income
- -791
- Net Income Before Taxes
- -796
- Net Income
- -850
- Diluted Normalized EPS
- -7.89
- Period
- 2024-03-31
- Total Assets
- 36756
- Total Liabilities
- 14515
- Total Equity
- 22241
- Tangible Book Valueper Share Common Eq
- 456.55
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 3016
- Cashfrom Investing Activities
- -610
- Cashfrom Financing Activities
- -2494
- Net Changein Cash
- -83
- Period
- 2023-12-31
- Total Revenue
- 3730
- Selling/ General/ Admin Expenses Total
- 1025
- Depreciation/ Amortization
- 246
- Other Operating Expenses Total
- 761
- Total Operating Expense
- 3434
- Operating Income
- 296
- Net Income Before Taxes
- 262
- Net Income
- 158
- Diluted Normalized EPS
- 6.2
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 3998
- Selling/ General/ Admin Expenses Total
- 977
- Depreciation/ Amortization
- 234
- Other Operating Expenses Total
- 731
- Total Operating Expense
- 3311
- Operating Income
- 687
- Net Income Before Taxes
- 615
- Net Income
- 428
- Diluted Normalized EPS
- 13.58
- Period
- 2023-09-30
- Total Assets
- 35907
- Total Liabilities
- 14504
- Total Equity
- 21403
- Tangible Book Valueper Share Common Eq
- 424.64
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 1493
- Cashfrom Investing Activities
- 223
- Cashfrom Financing Activities
- -1597
- Net Changein Cash
- 123
- Period
- 2023-06-30
- Total Revenue
- 4218
- Selling/ General/ Admin Expenses Total
- 987
- Depreciation/ Amortization
- 229
- Other Operating Expenses Total
- 797
- Total Operating Expense
- 3404
- Operating Income
- 814
- Net Income Before Taxes
- 749
- Net Income
- 532
- Diluted Normalized EPS
- 20.53
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 4407
- Selling/ General/ Admin Expenses Total
- 1044
- Depreciation/ Amortization
- 234
- Other Operating Expenses Total
- 804
- Total Operating Expense
- 3676
- Operating Income
- 731
- Net Income Before Taxes
- 686
- Net Income
- 709
- Diluted Normalized EPS
- 28.67
- Period
- 2023-03-31
- Total Assets
- 35084
- Total Liabilities
- 15363
- Total Equity
- 19721
- Tangible Book Valueper Share Common Eq
- 360.78
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 2971
- Cashfrom Investing Activities
- -1186
- Cashfrom Financing Activities
- -2076
- Net Changein Cash
- -254
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Tata Chemicals Technical
Moving Average
SMA
- 5 Day1123.6
- 10 Day1125.53
- 20 Day1109.38
- 50 Day1077.19
- 100 Day1078.25
- 300 Day1072.39
Tata Chemicals Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Deepak Nitrite
- 2655.2
- -60.75
- -2.24
- 3168.65
- 1924.75
- 36216.93
- BASF India
- 6926.2
- -466.7
- -6.31
- 8748.1
- 2421.35
- 29980.5
- Tata Chemicals
- 1056.55
- -50.7
- -4.58
- 1349.7
- 933
- 26942.02
- Bayer Cropscience
- 6347.8
- -2.7
- -0.04
- 7189.9
- 4820
- 28501.62
- Himadri Speciality Chemical
- 550.85
- -26.6
- -4.61
- 688.5
- 223.8
- 27134.57
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Deepak Nitrite
- 49.72
- 7.78
- 28.82
- 13.26
- BASF India
- 58.52
- 10.2
- 20.57
- 3.7
- Tata Chemicals
- 37.99
- 1.29
- 5.98
- 8.82
- Bayer Cropscience
- 37.66
- 10.01
- 24.11
- 13.62
- Himadri Speciality Chemical
- 62.41
- 9.25
- 8.49
- 5.8
Tata Chemicals Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 17-Oct-24
- Quarterly Results
- 05-Aug-24
- Quarterly Results
- 29-Apr-24
- Audited Results, Dividend & Others
- 05-Feb-24
- Quarterly Results
- 10-Nov-23
- Quarterly Results
- 07-Aug-23
- Quarterly Results
- 03-May-23
- Audited Results & Final Dividend
- 01-Feb-23
- Quarterly Results
- 27-Oct-22
- Quarterly Results
- 09-Aug-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 26-Jun-24
- 21-May-24
- AGM
- 26-Jun-23
- 16-May-23
- AGM
- 25-Mar-23
- 21-Feb-23
- POM
- 06-Jul-22
- 29-Apr-22
- AGM
- 02-Jul-21
- 03-May-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 29-Apr-24
- 12-Jun-24
- 12-Jun-24
- 15
- 03-May-23
- -
- 14-Jun-23
- 17.5
- 29-Apr-22
- -
- 15-Jun-22
- 12.5
- 03-May-21
- -
- 14-Jun-21
- 10